Survival of almost 3,000 consecutive patients treated on ECOG protocols for newly diagnosed acute myeloid leukemia (AML) since 1973. The only exclusion from this curve is acute promyelocytic leukemia (APL) patients treated on all-trans retinoic acid (ATRA).